Is EDSS Enough to Predict Risk of Upper Urinary Tract Damage in Patients with Multiple Sclerosis?

Lower urinary tract dysfunction is often observed in patients with multiple sclerosis (MS) and may be responsible for an increased risk of upper urinary tract (UUT) damage. Although there are well-known urodynamic risk factors for UUT damage, no clinical prediction parameters are clearly identified. We aimed to confirm the accuracy of the Expanded Disability Status Scale (EDSS) in predicting urodynamic risk factors for UUT deterioration and to assess other clinical parameters potentially predicting urodynamic risk factors. We retrospectively reviewed 201 patients with MS referred for primary neuro-urological work-up, including a video-urodynamic study (VUDS) from August 2009 to February 2020. Multivariate modeling revealed EDSS, male gender, and a number of LUTS as clinical parameters significantly associated with urodynamic risk factors for UUT damage (p = 0.06, p = 0.01, p = 0.02, respectively). A nomogram combining EDSS, male gender, and a number of different LUTS was created to predict the presence of at least one urodynamic risk factor for UUT damage. In conclusion, the presence of high EDSS combined with male gender and several different LUTS is significantly associated with urodynamic risk factors and can be used to stratify MS patients for further neuro-urological assessment and treatment.

[1]  S. Coote,et al.  Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis. , 2020, International journal of MS care.

[2]  A. Abello,et al.  Worsening disability status in multiple sclerosis predicts urologic complications , 2020, International Urology and Nephrology.

[3]  T. Kessler,et al.  High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis , 2018, Multiple sclerosis.

[4]  A. Peterson,et al.  Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults , 2016, Translational andrology and urology.

[5]  K. Coyne,et al.  The impact of lower urinary tract symptoms on health‐related quality of life among patients with multiple sclerosis , 2016, Neurourology and Urodynamics.

[6]  P. Marque,et al.  Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients , 2015, Neurourology and urodynamics.

[7]  Ariel Miller,et al.  Revised diagnostic criteria of multiple sclerosis. , 2014, Autoimmunity reviews.

[8]  C. Chapple.  International Continence Society guidelines on urodynamic equipment performance. , 2014, Neurourology and urodynamics.

[9]  G. Amarenco,et al.  First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm , 2013, Multiple sclerosis.

[10]  J. Petit,et al.  Facteurs pronostiques d'urétéro-hydronéphrose (UHN) chez les patients atteints de sclérose en plaques (SEP) Prognostics factors of renal failure in multiple sclerosis , 2012 .

[11]  R. Kirschner-Hermanns,et al.  Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases , 2013, World Journal of Urology.

[12]  M. Spinelli,et al.  Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group , 2011, Neurological Sciences.

[13]  J. Stoffel.  Contemporary management of the neurogenic bladder for multiple sclerosis patients. , 2010, The Urologic clinics of North America.

[14]  R. Freeman,et al.  An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction , 2010, Neurourology and urodynamics.

[15]  C. Fowler,et al.  A UK consensus on the management of the bladder in multiple sclerosis , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[16]  G. Lombardi,et al.  Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients , 2008, Neurological Sciences.

[17]  Pierre-Alain Joseph,et al.  The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines , 2007, Multiple sclerosis.

[18]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[19]  P. Rubenwolf.  [Prognostic value of urodynamic testing in myelodysplastic patients]. , 2003, Aktuelle Urologie.

[20]  R. Lawrenson,et al.  Renal Failure in Patients with Neurogenic Lower Urinary Tract Dysfunction , 2001, Neuroepidemiology.

[21]  G. Scivoletto,et al.  Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. , 1999, Archives of physical medicine and rehabilitation.

[22]  G. Scivoletto,et al.  Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients. , 1999, Neurourology and urodynamics.

[23]  O. Hommes,et al.  Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. , 1995, The Journal of urology.

[24]  T. Zampieri,et al.  Bladder hypocompliance in the spinal cord injury population. , 1989, The Journal of urology.

[25]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[26]  G. Aimard,et al.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. , 1980, Brain : a journal of neurology.

[27]  W. Samellas,et al.  MANAGEMENT OF UPPER URINARY TRACT COMPLICATIONS IN MULTIPLE SCLEROSIS BY MEANS OF URINARY DIVERSION TO AN ILEAL CONDUIT. , 1965, The Journal of urology.